Hints and tips:
...The FTC’s detailed opposition to the Horizon deal focuses on so-called pharmacy benefit managers. These businesses determine which drug prescriptions are eligible for health insurance reimbursement....
...The FTC argued that Amgen could use the rebates it pays on its existing “blockbuster” drugs to press insurance companies and pharmacy benefit managers into paying for two of Horizon’s medicines: Tepezza...
...The FTC argued that Amgen could use the rebates it pays on its “blockbuster” drugs to press insurance companies and pharmacy benefit managers into paying for two of Horizon’s medicines: Tepezza for an autoimmune...
...Amgen said it would offer its biologic treatment, named Amjevita, to US health insurers and middlemen known as pharmacy benefit managers through two pricing plans....
...cosmetics stores and pharmacy chain stores....
...Overall, Pfizer said it expected no revenue growth from higher prices in the US in 2020 — as was the case in 2019 — because of increases in the rebates they paid to middlemen called pharmacy benefit managers...
...Pharmacy benefit managers, known as PBMs, bridge the gap between drugmakers and insurers, deciding which drugs will be covered by insurance plans and negotiating rebates and discounts....
...The gap between a drug’s list price and its net price is often the result of rebates that go to middlemen called pharmacy benefit managers, and the proportion of the cost that a patient must contribute depends...
...Together the two companies will become one of the key managers of US government-sponsored healthcare plans, including Medicaid and Medicare, for 22m people across the 50 states....
...Many are likely to point the finger at pharmacy benefit managers, the companies that administer drug programmes for insurers....
...The drugmakers blame pharmacy benefit managers, which administer drugs for insurance plans, of keeping the cash rather than passing on savings to patients....
...Pfizer said given that it expects the price increases to be offset by the higher rebates and discounts paid to insurance companies and pharmacy benefits managers, the net effect on US revenue growth would...
...benefit manager....
...Cigna, a health insurer, announced the takeover of Express Scripts, a pharmacy benefit manager, in March....
...Insurer Cigna — which has struck a $67bn deal to buy Express Scripts, a large pharmacy benefits manager — was up about 0.88 per cent, while Express Scripts rose 2.35 per cent....
...CVS reports second-quarter results and is expected to benefit from higher sales of prescription drugs at its stores....
...benefits manager, by Cigna, another health insurer....
...Express Scripts was the last large independent pharmacy benefits manager, or PBM, which acts a middleman in negotiations between drugmakers and the payers — the employers, insurers, and government, which...
...The opioid issue extends to pharmacies and pharmacy benefit managers, which negotiate drug prices with manufacturers, says Seema Suchak, sustainable investment analyst at Schroders....
...insurer Cigna paying $67bn to take over Express Scripts, a pharmacy benefits manager that also delivers medication by mail....
...CVS has one of the largest pharmacy benefits managers, which oversee insurance payments for drugs. Rite Aid has a small PBM unit as well....
...pharmacy benefits managers (PBMs)....
...These middlemen, officially known as pharmacy benefit managers or PBMs, are unique to the private US healthcare system....
...Sanofi said it would lower the net price of Praluent for a significant proportion of patients covered by Express Scripts, the largest standalone pharmacy benefits manager (PBM) in the US....
...The move comes after months of speculation that Amazon was about to enter the healthcare industry, which has weighed on the share prices of insurers, drugmakers, wholesalers and pharmacy benefits managers...
International Edition